Cite
MLA Citation
Corinne Faivre-Finn et al.. “Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.” Lancet oncology, vol. 18, no. 8, n.d., pp. 1116–1125. http://access.bl.uk/ark:/81055/vdc_100049766196.0x000003